Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer.
Ryota Tanaka, Shimpei Eguchi, Kenjiro Kimura and 7 more
PLoS ONE · 2023
doi:10.1371/journal.pone.0280348 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
<h4>Background</h4>The impact of tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) on the prognosis of biliary tract cancer (BTC) is not completely understood. Therefore, in our study, we investigated the effects of the various immune cells infiltration in tumor microenvironment (TME).<h4>Methods</h4>A total of 130 patients with BTC who underwent surgical treatment at our institution were enrolled in this study. We retrospectively evaluated TILs and TAMs with immunohistochemical staining.<h4>Results</h4>With CD8-high, CD4-high, FOXP3-high, and CD68-low in TME as one factor, we calculated Immunoscore according to the number of factors. The high Immunoscore group showed significantly superior overall survival (OS) and recurrence-free survival (RFS) than the low Immunoscore group (median OS, 60.8 vs. 26.4 months, p = 0.001; median RFS not reached vs. 17.2 months, p < 0.001). Also, high Immunoscore was an independent good prognostic factor for OS and RFS (hazards ratio 2.05 and 2.41 and p = 0.01 and p = 0.001, respectively).<h4>Conclusions</h4>High Immunoscore group had significantly superior OS and RFS and was an independent good prognostic factor for OS and RFS.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.